(2S,3R,4S,5S,6R)-2-(((2R,3R,4S,5S,6R)-4,5-二羟基-2-(((1R,2S,4aR,4bR,6aR,6'S,7R,8S,10aR,10bR,12aS)-1-羟基-6'-((S)-1-羟基丙-2-基)-4a,4b,7,10a-四甲基-7-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-氧基))甲基)二十氢-1H-螺[屈-2,3'-吡喃]-8-氧基))-6-(羟甲基)四氢-2H-吡喃-3-氧基))-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇
β-D-Glucopyranoside, (1R,2S,4aR,4bR,6′S,6aR,7R,8S,10aR,10bR,12aS)-7-[(β-D-glucopyranosyloxy)methyl]octadecahydro-1-hydroxy-6′-[(1S)-2-hydroxy-1-methylethyl]-4a,4b,7,10a-tetramethylspiro[chrysene-2(1H),3′(4′H)-[2H]pyran]-8-yl 2-O-β-D-glucopyranosyl- (9CI)
产品编号 :
Cas No. :
标准英文名 :
分子式 :
分子量 :
MDL No. :
| 包装规格 | 交货周期 | 质量标准 | 品牌 | 目录价 | 会员专享价 | 数量 |
|---|---|---|---|---|---|---|
|
抱歉，暂无牌价信息 |
||||||
![β-D-Glucopyranoside, (1R,2S,4aR,4bR,6′S,6aR,7R,8S,10aR,10bR,12aS)-7-[(β-D-glucopyranosyloxy)methyl]octadecahydro-1-hydroxy-6′-[(1S)-2-hydroxy-1-methylethyl]-4a,4b,7,10a-tetramethylspiro[chrysene-2(1H),3′(4′H)-[2H]pyran]-8-yl 2-O-β-D-glucopyranosyl- (9CI)](/image/product/70078990.png?ts=1784672132)
基础信息
| GHS | |
|---|---|
| Smiles | C[C@]12[C@@]3(CC[C@]4(CO[C@]([H])([C@@H](C)CO)CC4)[C@H](O)[C@@]3([H])CC[C@]1([H])[C@]1(CC[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)[C@@](C)(CO[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)[C@]1([H])CC2)C)C |
| Inchi | InChI=1S/C48H82O20/c1-22(16-49)24-8-13-48(21-62-24)15-14-46(4)23(40(48)61)6-7-29-44(2)11-10-30(45(3,28(44)9-12-47(29,46)5)20-63-41-37(59)34(56)31(53)25(17-50)64-41)67-43-39(36(58)33(55)27(19-52)66-43)68-42-38(60)35(57)32(54)26(18-51)65-42/h22-43,49-61H,6-21H2,1-5H3/t22-,23+,24-,25+,26+,27+,28+,29+,30-,31+,32+,33+,34-,35-,36-,37+,38+,39+,40+,41+,42-,43-,44-,45-,46+,47+,48+/m0/s1 |
| InchiKey | JUKFJOYCFLIWIA-MDQYKXRHSA-N |
| 别名 | |
| 性状 | |
| 存储条件 | |
| 熔点 | |
| 闪点 | |
| 化学稳定性 | |
| 沸点 | |
| 密度 | |
| 海关编码 | |
| 手性 | |
| 生物活性 | |
| 理化性质 | |
| UN No. | |
| 特性 | |
| 用途 | |
| 蒸气压 | |
| 运输要求 | |
| 品牌 |
安全信息
| 危险类别码 | |
|---|---|
| 信号词 | |
| 水溶解性 | |
| 危险品分类 | |
| 安全说明 | |
| 存储要求 | |
| 危险品标志 | |
| 有害分解物 |
产品介绍
抱歉，暂无产品详情
相关文献
抱歉，暂无相关文献
浏览记录
![Immunoglobulin G4 [226-proline,de-445-lysine], anti-(human growth differentiation factor 15) (human-Mus musculus monoclonal CTL-002 γ4-chain), disulfide with human-Mus musculus monoclonal CTL-002 κ-chain, dimer (ACI)](/image/product/80078313.png?ts=1784672848)
![(3Z)-1,3-Dihydro-3-[4-oxo-3-(2-propen-1-yl)-2-thioxo-5-thiazolidinylidene]-2H-indol-2-one (ACI)](/image/product/10079205.png?ts=1784672827)
![2,5-Dioxo-1-pyrrolidinyl 3′,6′-bis(acetyloxy)-3-oxospiro[isobenzofuran-1(3H),9′-[9H]xanthene]-6-carboxylate (ACI)](/image/product/70078536.png?ts=1784672824)
![1,1-Dimethylethyl (2S)-4-[2-[[(2S,4R)-4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]-1-methyl-2-pyrrolidinyl]methoxy]-5,6,7,8-tetrahydro-7-(1-naphthalenyl)pyrido[3,4-d]pyrimidin-4-yl]-2-(cyanomethyl)-1-piperazinecarboxylate (ACI)](/image/product/40078761.png?ts=1784672148)
![2-[[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl]oxy]ethanamine (ACI)](/image/product/70079006.png?ts=1784672129)
![(6R,6aR,7S,12bS)-5,6,6a,7-Tetrahydro-7-hydroxy-2,3,12-trimethoxy-6,6a-dimethyl-1H-indeno[7′a,1′:1,2]indeno[5,6-d][1,3]dioxol-1-one (ACI)](/image/product/10079764.png?ts=1784672129)
![6-Amino-1,3-dimethyl-5-[2-(2-pyridinylthio)acetyl]-2,4(1H,3H)-pyrimidinedione (ACI)](/image/product/30078409.png?ts=1784672126)
![1-Butyl-1H-indole-2,3-dione 3-[2-(2-thiazolyl)hydrazone] (ACI)](/image/product/90078854.png?ts=1784672126)
